{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T05:05:42Z","timestamp":1791867942099,"version":"4.3.4"},"reference-count":83,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2019,10,14]],"date-time":"2019-10-14T00:00:00Z","timestamp":1571011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2019,10,14]],"date-time":"2019-10-14T00:00:00Z","timestamp":1571011200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100011098","name":"SU | Stanford Bio-X","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100011098","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"U.S. Department of Health & Human Services | NIH | National Cancer Institute","doi-asserted-by":"publisher","award":["K08 CA207882"],"award-info":[{"award-number":["K08 CA207882"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000092","name":"U.S. Department of Health & Human Services | NIH | U.S. National Library of Medicine","doi-asserted-by":"publisher","award":["GM 102365"],"award-info":[{"award-number":["GM 102365"]}],"id":[{"id":"10.13039\/100000092","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Biotechnol"],"published-print":{"date-parts":[[2019,11]]},"DOI":"10.1038\/s41587-019-0280-2","type":"journal-article","created":{"date-parts":[[2019,10,14]],"date-time":"2019-10-14T12:08:10Z","timestamp":1571054890000},"page":"1332-1343","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":319,"title":["Predicting HLA class II antigen presentation through integrated deep learning"],"prefix":"10.1038","volume":"37","author":[{"given":"Binbin","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael S.","family":"Khodadoust","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9746-0542","authenticated-orcid":false,"given":"Niclas","family":"Olsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa E.","family":"Wagar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ethan","family":"Fast","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chih Long","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yagmur","family":"Muftuoglu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian J.","family":"Sworder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2032-0581","authenticated-orcid":false,"given":"Maximilian","family":"Diehn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronald","family":"Levy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6868-657X","authenticated-orcid":false,"given":"Mark M.","family":"Davis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8063-3259","authenticated-orcid":false,"given":"Joshua E.","family":"Elias","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Russ B.","family":"Altman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5153-5625","authenticated-orcid":false,"given":"Ash A.","family":"Alizadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,10,14]]},"reference":[{"key":"280_CR1","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1038\/nri3084","volume":"11","author":"J Neefjes","year":"2011","unstructured":"Neefjes, J., Jongsma, M. L., Paul, P. & Bakke, O. Towards a systems understanding of MHC class I and MHC class II antigen presentation. Nat. Rev. Immunol. 11, 823\u2013836 (2011).","journal-title":"Nat. Rev. Immunol."},{"key":"280_CR2","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1038\/nature21433","volume":"543","author":"MS Khodadoust","year":"2017","unstructured":"Khodadoust, M. S. et al. Antigen presentation profiling reveals recognition of lymphoma immunoglobulin neoantigens. Nature 543, 723\u2013727 (2017).","journal-title":"Nature"},{"key":"280_CR3","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms13404","volume":"7","author":"M Bassani-Sternberg","year":"2016","unstructured":"Bassani-Sternberg, M. et al. Direct identification of clinically relevant neoepitopes presented on native human melanoma tissue by mass spectrometry. Nat. Commun. 7, 13404 (2016).","journal-title":"Nat. Commun."},{"key":"280_CR4","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1084\/jem.189.5.753","volume":"189","author":"RE Toes","year":"1999","unstructured":"Toes, R. E., Ossendorp, F., Offringa, R. & Melief, C. J. CD4 T cells and their role in antitumor immune responses. J. Exp. Med. 189, 753\u2013756 (1999).","journal-title":"J. Exp. Med."},{"key":"280_CR5","doi-asserted-by":"publisher","first-page":"1565","DOI":"10.1126\/science.1203486","volume":"331","author":"RD Schreiber","year":"2011","unstructured":"Schreiber, R. D., Old, L. J. & Smyth, M. J. Cancer immunoediting: integrating immunity\u2019s roles in cancer suppression and promotion. Science 331, 1565\u20131570 (2011).","journal-title":"Science"},{"key":"280_CR6","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1038\/nm.3773","volume":"21","author":"C Linnemann","year":"2015","unstructured":"Linnemann, C. et al. High-throughput epitope discovery reveals frequent recognition of neo-antigens by CD4+ T cells in human melanoma. Nat. Med. 21, 81 (2015).","journal-title":"Nat. Med."},{"key":"280_CR7","doi-asserted-by":"publisher","first-page":"1387","DOI":"10.1126\/science.aad1253","volume":"350","author":"E Tran","year":"2015","unstructured":"Tran, E. et al. Immunogenicity of somatic mutations in human gastrointestinal cancers. Science 350, 1387\u20131390 (2015).","journal-title":"Science"},{"key":"280_CR8","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1038\/nature23003","volume":"547","author":"U Sahin","year":"2017","unstructured":"Sahin, U. et al. Personalized RNA mutanome vaccines mobilize poly-specific therapeutic immunity against cancer. Nature 547, 222\u2013226 (2017).","journal-title":"Nature"},{"key":"280_CR9","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1038\/nature22991","volume":"547","author":"PA Ott","year":"2017","unstructured":"Ott, P. A. et al. An immunogenic personal neoantigen vaccine for patients with melanoma. Nature 547, 217\u2013221 (2017).","journal-title":"Nature"},{"key":"280_CR10","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1126\/science.aad0095","volume":"350","author":"EM Van Allen","year":"2015","unstructured":"Van Allen, E. M. et al. Genomic correlates of response to CTLA-4 blockade in metastatic melanoma. Science 350, 207\u2013211 (2015).","journal-title":"Science"},{"key":"280_CR11","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1038\/nature14426","volume":"520","author":"S Kreiter","year":"2015","unstructured":"Kreiter, S. et al. Mutant MHC class II epitopes drive therapeutic immune responses to cancer. Nature 520, 692\u2013696 (2015).","journal-title":"Nature"},{"key":"280_CR12","doi-asserted-by":"crossref","unstructured":"The problem with neoantigen prediction. Nat. Biotechnol. 35, 97 (2017).","DOI":"10.1038\/nbt.3800"},{"key":"280_CR13","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1007\/s12026-014-8505-4","volume":"58","author":"MS Khodadoust","year":"2014","unstructured":"Khodadoust, M. S. & Alizadeh, A. A. Tumor antigen discovery through translation of the cancer genome. Immunol. Res. 58, 292\u2013299 (2014).","journal-title":"Immunol. Res."},{"key":"280_CR14","doi-asserted-by":"publisher","first-page":"4667","DOI":"10.1074\/jbc.RA118.006704","volume":"294","author":"DL Moss","year":"2019","unstructured":"Moss, D. L., Park, H. W., Mettu, R. R. & Landry, S. J. Deimmunizing substitutions in Pseudomonas exotoxin domain III perturb antigen processing without eliminating T-cell epitopes. J. Biol. Chem. 294, 4667\u20134681 (2019).","journal-title":"J. Biol. Chem."},{"key":"280_CR15","doi-asserted-by":"publisher","first-page":"1522","DOI":"10.1093\/bioinformatics\/btx820","volume":"34","author":"M Andreatta","year":"2017","unstructured":"Andreatta, M. et al. An automated benchmarking platform for MHC class II binding prediction methods. Bioinformatics 34, 1522\u20131528 (2017).","journal-title":"Bioinformatics"},{"key":"280_CR16","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1016\/j.cell.2018.08.048","volume":"175","author":"R Marty","year":"2018","unstructured":"Marty, R., Thompson, W. K., Salem, R. M., Zanetti, M. & Carter, H. Evolutionary pressure against MHC class II binding cancer mutations. Cell 175, 416\u2013428 (2018).","journal-title":"Cell"},{"key":"280_CR17","doi-asserted-by":"publisher","first-page":"e1006457","DOI":"10.1371\/journal.pcbi.1006457","volume":"14","author":"W Zhao","year":"2018","unstructured":"Zhao, W. & Sher, X. Systematically benchmarking peptide-MHC binding predictors: from synthetic to naturally processed epitopes. PLoS Comput. Biol. 14, e1006457 (2018).","journal-title":"PLoS Comput. Biol."},{"key":"280_CR18","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1038\/nature14001","volume":"515","author":"M Yadav","year":"2014","unstructured":"Yadav, M. et al. Predicting immunogenic tumour mutations by combining mass spectrometry and exome sequencing. Nature 515, 572\u2013576 (2014).","journal-title":"Nature"},{"key":"280_CR19","doi-asserted-by":"publisher","first-page":"3105","DOI":"10.1074\/mcp.O115.052431","volume":"14","author":"E Caron","year":"2015","unstructured":"Caron, E. et al. Analysis of major histocompatibility complex (MHC) immunopeptidomes using mass spectrometry. Mol. Cell. Proteomics 14, 3105\u20133117 (2015).","journal-title":"Mol. Cell. Proteomics"},{"key":"280_CR20","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/j.immuni.2017.02.007","volume":"46","author":"JG Abelin","year":"2017","unstructured":"Abelin, J. G. et al. Mass spectrometry profiling of HLA-associated peptidomes in mono-allelic cells enables more accurate epitope prediction. Immunity 46, 315\u2013326 (2017).","journal-title":"Immunity"},{"key":"280_CR21","doi-asserted-by":"publisher","first-page":"D405","DOI":"10.1093\/nar\/gku938","volume":"43","author":"R Vita","year":"2015","unstructured":"Vita, R. et al. The immune epitope database (IEDB) 3.0. Nucleic Acids Res. 43, D405\u2013D412 (2015).","journal-title":"Nucleic Acids Res."},{"key":"280_CR22","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1007\/s00251-015-0873-y","volume":"67","author":"M Andreatta","year":"2015","unstructured":"Andreatta, M. et al. Accurate pan-specific prediction of peptide-MHC class II binding affinity with improved binding core identification. Immunogenetics 67, 641\u2013650 (2015).","journal-title":"Immunogenetics"},{"key":"280_CR23","doi-asserted-by":"publisher","first-page":"1795","DOI":"10.3389\/fimmu.2018.01795","volume":"9","author":"S Paul","year":"2018","unstructured":"Paul, S. et al. Determination of a predictive cleavage motif for eluted major histocompatibility complex class II ligands. Front. Immunol. 9, 1795 (2018).","journal-title":"Front. Immunol."},{"key":"280_CR24","doi-asserted-by":"publisher","first-page":"1735","DOI":"10.1162\/neco.1997.9.8.1735","volume":"9","author":"S Hochreiter","year":"1997","unstructured":"Hochreiter, S. & Schmidhuber, J. Long short-term memory. Neural Computation 9, 1735\u20131780 (1997).","journal-title":"Neural Computation"},{"key":"280_CR25","doi-asserted-by":"crossref","unstructured":"Liu, H., Han, F., Zhou, H., Yan, X. & Kosik, K. S. Fast motif discovery in short sequences. In Proc. 32nd IEEE International Conference on Data Engineering 1158\u20131169 (IEEE, 2016).","DOI":"10.1109\/ICDE.2016.7498321"},{"key":"280_CR26","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2105-8-238","volume":"8","author":"M Nielsen","year":"2007","unstructured":"Nielsen, M., Lundegaard, C. & Lund, O. Prediction of MHC class II binding affinity using SMM-align, a novel stabilization matrix alignment method. BMC Bioinformatics 8, 238 (2007).","journal-title":"BMC Bioinformatics"},{"key":"280_CR27","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2105-10-296","volume":"10","author":"M Nielsen","year":"2009","unstructured":"Nielsen, M. & Lund, O. NN-align. An artificial neural network-based alignment algorithm for MHC class II peptide binding prediction. BMC Bioinformatics 10, 296 (2009).","journal-title":"BMC Bioinformatics"},{"key":"280_CR28","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1038\/9858","volume":"17","author":"T Sturniolo","year":"1999","unstructured":"Sturniolo, T. et al. Generation of tissue-specific and promiscuous HLA ligand databases using DNA microarrays and virtual HLA class II matrices. Nat. Biotechnol. 17, 555\u2013561 (1999).","journal-title":"Nat. Biotechnol."},{"key":"280_CR29","doi-asserted-by":"publisher","DOI":"10.1186\/1745-7580-4-2","volume":"4","author":"J Sidney","year":"2008","unstructured":"Sidney, J. et al. Quantitative peptide binding motifs for 19 human and mouse MHC class I molecules derived using positional scanning combinatorial peptide libraries. Immunome Res. 4, 2 (2008).","journal-title":"Immunome Res."},{"key":"280_CR30","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2105-11-568","volume":"11","author":"P Wang","year":"2010","unstructured":"Wang, P. et al. Peptide binding predictions for HLA DR, DP and DQ molecules. BMC Bioinformatics 11, 568 (2010).","journal-title":"BMC Bioinformatics"},{"key":"280_CR31","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1111\/j.1365-2249.2005.02783.x","volume":"140","author":"R Ciccocioppo","year":"2005","unstructured":"Ciccocioppo, R., Di Sabatino, A. & Corazza, G. R. The immune recognition of gluten in coeliac disease. Clin. Exp. Immunol. 140, 408\u2013416 (2005).","journal-title":"Clin. Exp. Immunol."},{"key":"280_CR32","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1007\/s00251-014-0819-9","volume":"67","author":"E Bergseng","year":"2015","unstructured":"Bergseng, E. et al. Different binding motifs of the celiac disease-associated HLA molecules DQ2.5, DQ2.2, and DQ7.5 revealed by relative quantitative proteomics of endogenous peptide repertoires. Immunogenetics 67, 73\u201384 (2015).","journal-title":"Immunogenetics"},{"key":"280_CR33","doi-asserted-by":"publisher","first-page":"4497","DOI":"10.4049\/jimmunol.1301466","volume":"193","author":"S Dorum","year":"2014","unstructured":"Dorum, S. et al. HLA-DQ molecules as affinity matrix for identification of gluten T cell epitopes. J. Immunol. 193, 4497\u20134506 (2014).","journal-title":"J. Immunol."},{"key":"280_CR34","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1007\/BF00188785","volume":"39","author":"K Falk","year":"1994","unstructured":"Falk, K., Rotzschke, O., Stevanovic, S., Jung, G. & Rammensee, H. G. Pool sequencing of natural HLA-DR, DQ, and DP ligands reveals detailed peptide motifs, constraints of processing, and general rules. Immunogenetics 39, 230\u2013242 (1994).","journal-title":"Immunogenetics"},{"key":"280_CR35","doi-asserted-by":"crossref","first-page":"4935","DOI":"10.4049\/jimmunol.159.10.4935","volume":"159","author":"RM Chicz","year":"1997","unstructured":"Chicz, R. M., Graziano, D. F., Trucco, M., Strominger, J. L. & Gorga, J. C. HLA-DP2: self peptide sequences and binding properties. J. Immunol. 159, 4935\u20134942 (1997).","journal-title":"J. Immunol."},{"key":"280_CR36","doi-asserted-by":"publisher","first-page":"900","DOI":"10.1021\/acs.jproteome.8b00595","volume":"18","author":"E Lorente","year":"2019","unstructured":"Lorente, E. et al. Proteomics analysis reveals that structural proteins of the virion core and involved in gene expression are the main source for HLA class II ligands in vaccinia virus-infected cells. J. Proteome Res. 18, 900\u2013911 (2019).","journal-title":"J. Proteome Res."},{"key":"280_CR37","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1074\/mcp.TIR117.000383","volume":"17","author":"C Chong","year":"2018","unstructured":"Chong, C. et al. High-throughput and sensitive immunopeptidomics platform reveals profound interferongamma-mediated remodeling of the human leukocyte antigen (HLA) ligandome. Mol. Cell Proteomics 17, 533\u2013548 (2018).","journal-title":"Mol. Cell Proteomics"},{"key":"280_CR38","doi-asserted-by":"publisher","first-page":"h988","DOI":"10.1136\/bmj.h988","volume":"350","author":"LH Butterfield","year":"2015","unstructured":"Butterfield, L. H State of the art review: cancer vaccines. BMJ 350, h988 (2015).","journal-title":"BMJ"},{"key":"280_CR39","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.cels.2018.05.014","volume":"7","author":"TJ O'Donnell","year":"2018","unstructured":"O'Donnell, T.J. et al. MHCflurry: open-source class I MHC binding affinity prediction. Cell Syst. 7, 129\u2013132 (2018).","journal-title":"Cell Syst."},{"key":"280_CR40","doi-asserted-by":"crossref","unstructured":"Rubinsteyn, A., Hodes, I., Kodysh, J. & Hammerbacher, J. Vaxrank: a computational tool for designing personalized cancer vaccines. Preprint at biorXiv https:\/\/www.biorxiv.org\/content\/10.1101\/142919v2 (2017).","DOI":"10.1101\/142919"},{"key":"280_CR41","doi-asserted-by":"publisher","first-page":"2491","DOI":"10.1158\/1078-0432.CCR-16-2680","volume":"23","author":"M Parkhurst","year":"2017","unstructured":"Parkhurst, M. et al. Isolation of T-Cell receptors specifically reactive with mutated tumor-associated antigens from tumor-infiltrating lymphocytes based on CD137 expression. Clinical Can. Res. 23, 2491\u20132505 (2017).","journal-title":"Clinical Can. Res."},{"key":"280_CR42","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1038\/s41591-018-0040-8","volume":"24","author":"N Zacharakis","year":"2018","unstructured":"Zacharakis, N. et al. Immune recognition of somatic mutations leading to complete durable regression in metastatic breast cancer. Nat. Med. 24, 724\u2013730 (2018).","journal-title":"Nat. Med."},{"key":"280_CR43","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1126\/science.aak9510","volume":"356","author":"S Stevanovic","year":"2017","unstructured":"Stevanovic, S. et al. Landscape of immunogenic tumor antigens in successful immunotherapy of virally induced epithelial cancer. Science 356, 200\u2013205 (2017).","journal-title":"Science"},{"key":"280_CR44","doi-asserted-by":"publisher","first-page":"266","DOI":"10.3390\/cancers11020266","volume":"11","author":"S Iiizumi","year":"2019","unstructured":"Iiizumi, S et al. Identification of novel HLA Class II-restricted neoantigens derived from driver mutations. Cancers (Basel) 11, 266 (2019).","journal-title":"Cancers (Basel)"},{"key":"280_CR45","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1038\/s41586-018-0792-9","volume":"565","author":"DB Keskin","year":"2019","unstructured":"Keskin, D. B. et al. Neoantigen vaccine generates intratumoral T cell responses in phase Ib glioblastoma trial. Nature 565, 234\u2013239 (2019).","journal-title":"Nature"},{"key":"280_CR46","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.3389\/fimmu.2017.01367","volume":"8","author":"M Muller","year":"2017","unstructured":"Muller, M., Gfeller, D., Coukos, G. & Bassani-Sternberg, M. \u2018Hotspots\u2019 of antigen presentation revealed by human leukocyte antigen ligandomics for neoantigen prioritization. Front. Immunol. 8, 1367 (2017).","journal-title":"Front. Immunol."},{"key":"280_CR47","first-page":"21","volume":"9","author":"H Luo","year":"2015","unstructured":"Luo, H. et al. Machine learning methods for predicting HLA-peptide binding activity. Bioinform. Biol. Insights. 9, 21\u201329 (2015).","journal-title":"Bioinform. Biol. Insights."},{"key":"280_CR48","doi-asserted-by":"publisher","first-page":"e1005725","DOI":"10.1371\/journal.pcbi.1005725","volume":"13","author":"M Bassani-Sternberg","year":"2017","unstructured":"Bassani-Sternberg, M. et al. Deciphering HLA-I motifs across HLA peptidomes improves neo-antigen predictions and identifies allostery regulating HLA specificity. PLoS Comput. Biol. 13, e1005725 (2017).","journal-title":"PLoS Comput. Biol."},{"key":"280_CR49","doi-asserted-by":"publisher","first-page":"3360","DOI":"10.4049\/jimmunol.1700893","volume":"199","author":"V Jurtz","year":"2017","unstructured":"Jurtz, V. et al. NetMHCpan-4.0: improved peptide-MHC class I interaction predictions integrating eluted ligand and peptide binding affinity data. J. Immunol. 199, 3360\u20133368 (2017).","journal-title":"J. Immunol."},{"key":"280_CR50","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1074\/mcp.M114.042812","volume":"14","author":"M Bassani-Sternberg","year":"2015","unstructured":"Bassani-Sternberg, M., Pletscher-Frankild, S., Jensen, L. J. & Mann, M. Mass spectrometry of human leukocyte antigen class I peptidomes reveals strong effects of protein abundance and turnover on antigen presentation. Mol. Cell Proteomics 14, 658\u2013673 (2015).","journal-title":"Mol. Cell Proteomics"},{"key":"280_CR51","doi-asserted-by":"publisher","first-page":"D1237","DOI":"10.1093\/nar\/gkx664","volume":"46","author":"W Shao","year":"2018","unstructured":"Shao, W. et al. The SysteMHC Atlas project. Nucleic Acids Res. 46, D1237\u2013D1247 (2018).","journal-title":"Nucleic Acids Res."},{"key":"280_CR52","doi-asserted-by":"crossref","unstructured":"Racle, J. et al. Deep motif deconvolution of HLA-II peptidomes for robust class II epitope predictions. Preprint at biorXiv https:\/\/www.biorxiv.org\/content\/10.1101\/539338v1 (2019).","DOI":"10.1101\/539338"},{"key":"280_CR53","unstructured":"Bhattacharya, R. et al. Prediction of peptide binding to MHC Class I proteins in the age of deep learning. Preprint at biorXiv https:\/\/www.biorxiv.org\/content\/10.1101\/154757v1 (2017)."},{"key":"280_CR54","doi-asserted-by":"publisher","first-page":"1412","DOI":"10.1074\/mcp.M115.055780","volume":"15","author":"GP Mommen","year":"2016","unstructured":"Mommen, G. P. et al. Sampling from the proteome to the human leukocyte antigen-DR (HLA-DR) ligandome proceeds via high specificity. Mol. Cell Proteomics 15, 1412\u20131423 (2016).","journal-title":"Mol. Cell Proteomics"},{"key":"280_CR55","doi-asserted-by":"publisher","first-page":"1762","DOI":"10.1038\/s41591-018-0203-7","volume":"24","author":"DB Graham","year":"2018","unstructured":"Graham, D. B. et al. Antigen discovery and specification of immunodominance hierarchies for MHCII-restricted epitopes. Nat. Med. 24, 1762\u20131772 (2018).","journal-title":"Nat. Med."},{"key":"280_CR56","doi-asserted-by":"publisher","first-page":"1585","DOI":"10.1074\/mcp.M113.033308","volume":"13","author":"B Forsstrom","year":"2014","unstructured":"Forsstrom, B. et al. Proteome-wide epitope mapping of antibodies using ultra-dense peptide arrays. Mol. Cell Proteomics 13, 1585\u20131597 (2014).","journal-title":"Mol. Cell Proteomics"},{"key":"280_CR57","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1111\/imm.12160","volume":"141","author":"KW Jorgensen","year":"2014","unstructured":"Jorgensen, K. W., Rasmussen, M., Buus, S. & Nielsen, M. NetMHCstab\u2014predicting stability of peptide\u2013MHC-I complexes; impacts for cytotoxic T lymphocyte epitope discovery. Immunology 141, 18\u201326 (2014).","journal-title":"Immunology"},{"key":"280_CR58","doi-asserted-by":"publisher","first-page":"e1004796","DOI":"10.1371\/journal.pcbi.1004796","volume":"12","author":"L Boelen","year":"2016","unstructured":"Boelen, L. et al. BIITE: a tool to determine HLA class II epitopes from T cell ELISpot data. PLoS Comput. Biol. 12, e1004796 (2016).","journal-title":"PLoS Comput. Biol."},{"key":"280_CR59","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1038\/s41591-018-0316-z","volume":"25","author":"A Esteva","year":"2019","unstructured":"Esteva, A. et al. A guide to deep learning in healthcare. Nat. Med. 25, 24\u201329 (2019).","journal-title":"Nat. Med."},{"key":"280_CR60","doi-asserted-by":"publisher","first-page":"W543","DOI":"10.1093\/nar\/gkv385","volume":"43","author":"D Maddelein","year":"2015","unstructured":"Maddelein, D. et al. The IceLogo web server and SOAP service for determining protein consensus sequences. Nucleic Acids Res. 43, W543\u2013W546 (2015).","journal-title":"Nucleic Acids Res."},{"key":"280_CR61","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1038\/nprot.2006.37","volume":"1","author":"G Tiscornia","year":"2006","unstructured":"Tiscornia, G., Singer, O. & Verma, I. M. Production and purification of lentiviral vectors. Nat. Protoc. 1, 241\u2013245 (2006).","journal-title":"Nat. Protoc."},{"key":"280_CR62","doi-asserted-by":"publisher","first-page":"21795","DOI":"10.1073\/pnas.0911472106","volume":"106","author":"H Fujita","year":"2009","unstructured":"Fujita, H. et al. Human Langerhans cells induce distinct IL-22-producing CD4+ T cells lacking IL-17 production. Proc. Natl Acad. Sci. USA 106, 21795\u201321800 (2009).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"280_CR63","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.1126\/science.1546328","volume":"255","author":"DF Hunt","year":"1992","unstructured":"Hunt, D. F. et al. Characterization of peptides bound to the class I MHC molecule HLA-A2.1 by mass spectrometry. Science 255, 1261\u20131263 (1992).","journal-title":"Science"},{"key":"280_CR64","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1186\/1471-2164-15-325","volume":"15","author":"Y Bai","year":"2014","unstructured":"Bai, Y., Ni, M., Cooper, B., Wei, Y. & Fury, W. Inference of high resolution HLA types using genome-wide RNA or DNA sequencing reads. BMC Genomics 15, 325 (2014).","journal-title":"BMC Genomics"},{"key":"280_CR65","doi-asserted-by":"publisher","first-page":"S7","DOI":"10.1186\/1471-2164-16-S2-S7","volume":"16","author":"N Nariai","year":"2015","unstructured":"Nariai, N. et al. HLA-VBSeq: accurate HLA typing at full resolution from whole-genome sequencing data. BMC Genomics 16, S7 (2015).","journal-title":"BMC Genomics"},{"key":"280_CR66","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1038\/nature18945","volume":"536","author":"EM Verdegaal","year":"2016","unstructured":"Verdegaal, E. M. et al. Neoantigen landscape dynamics during human melanoma\u2013T cell interactions. Nature 536, 91\u201395 (2016).","journal-title":"Nature"},{"key":"280_CR67","doi-asserted-by":"publisher","first-page":"1681","DOI":"10.1016\/j.cell.2015.05.044","volume":"161","author":"The Cancer Genome Atlas Network","year":"2015","unstructured":"The Cancer Genome Atlas Network Genomic classification of cutaneous melanoma. Cell 161, 1681\u20131696 (2015).","journal-title":"Cell"},{"key":"280_CR68","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1038\/nm.3435","volume":"20","author":"R Rahal","year":"2014","unstructured":"Rahal, R. et al. Pharmacological and genomic profiling identifies NF-\u03baB-targeted treatment strategies for mantle cell lymphoma. Nat. Med. 20, 87\u201392 (2014).","journal-title":"Nat. Med."},{"key":"280_CR69","doi-asserted-by":"crossref","unstructured":"The ENCODE Project Consortium. A user\u2019s guide to the encyclopedia of DNA elements (ENCODE). PLoS Biol. 9, e1001046 (2011).","DOI":"10.1371\/journal.pbio.1001046"},{"key":"280_CR70","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2105-10-73","volume":"10","author":"J Chen","year":"2009","unstructured":"Chen, J., Aronow, B. J. & Jegga, A. G. Disease candidate gene identification and prioritization using protein interaction networks. BMC Bioinformatics 10, 73 (2009).","journal-title":"BMC Bioinformatics"},{"key":"280_CR71","doi-asserted-by":"publisher","first-page":"2699","DOI":"10.1093\/nar\/gky092","volume":"46","author":"The UniProt Consortium","year":"2018","unstructured":"The UniProt Consortium UniProt: the universal protein knowledgebase. Nucleic Acids Res. 46, 2699 (2018).","journal-title":"Nucleic Acids Res."},{"key":"280_CR72","doi-asserted-by":"publisher","first-page":"10915","DOI":"10.1073\/pnas.89.22.10915","volume":"89","author":"S Henikoff","year":"1992","unstructured":"Henikoff, S. & Henikoff, J. G. Amino acid substitution matrices from protein blocks. Proc. Natl Acad. Sci. USA 89, 10915\u201310919 (1992).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"280_CR73","doi-asserted-by":"publisher","first-page":"e0141287","DOI":"10.1371\/journal.pone.0141287","volume":"10","author":"E Asgari","year":"2015","unstructured":"Asgari, E. & Mofrad, M. R. Continuous distributed representation of biological sequences for deep proteomics and genomics. PLoS One 10, e0141287 (2015).","journal-title":"PLoS One"},{"key":"280_CR74","unstructured":"Nair, V. & Hinton, G. E. Rectified linear units improve restricted Boltzmann machines. In Proc. 27th International Conference on Machine Learning (Eds. Fuernkranz, J. & Joachims, T.) 807\u2013814 (Omnipress, 2010)."},{"key":"280_CR75","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1007\/s00251-013-0720-y","volume":"65","author":"E Karosiene","year":"2013","unstructured":"Karosiene, E. et al. NetMHCIIpan-3.0, a common pan-specific MHC class II prediction method including all three human MHC class II isotypes, HLA-DR, HLA-DP and HLA-DQ. Immunogenetics 65, 711\u2013724 (2013).","journal-title":"Immunogenetics"},{"key":"280_CR76","doi-asserted-by":"publisher","DOI":"10.1186\/1745-7580-6-9","volume":"6","author":"M Nielsen","year":"2010","unstructured":"Nielsen, M., Justesen, S., Lund, O., Lundegaard, C. & Buus, S. NetMHCIIpan-2.0\u2014improved pan-specific HLA-DR predictions using a novel concurrent alignment and weight optimization training procedure. Immunome Res. 6, 9 (2010).","journal-title":"Immunome Res."},{"key":"280_CR77","doi-asserted-by":"publisher","first-page":"1422","DOI":"10.1093\/bioinformatics\/btp163","volume":"25","author":"PJ Cock","year":"2009","unstructured":"Cock, P. J. et al. Biopython: freely available Python tools for computational molecular biology and bioinformatics. Bioinformatics 25, 1422\u20131423 (2009).","journal-title":"Bioinformatics"},{"key":"280_CR78","doi-asserted-by":"publisher","first-page":"D413","DOI":"10.1093\/nar\/gku1056","volume":"43","author":"MP Lefranc","year":"2015","unstructured":"Lefranc, M. P. et al. IMGT, the international ImMunoGeneTics information system 25 years on. Nucleic Acids Res. 43, D413\u2013D422 (2015).","journal-title":"Nucleic Acids Res."},{"key":"280_CR79","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1126\/science.1251102","volume":"344","author":"E Tran","year":"2014","unstructured":"Tran, E. et al. Cancer immunotherapy based on mutation-specific CD4+ T cells in a patient with epithelial cancer. Science 344, 641\u2013645 (2014).","journal-title":"Science"},{"key":"280_CR80","doi-asserted-by":"publisher","first-page":"1369","DOI":"10.3389\/fimmu.2018.01369","volume":"9","author":"SK Dhanda","year":"2018","unstructured":"Dhanda, S. K. et al. Predicting HLA CD4 immunogenicity in human populations. Front. Immunol. 9, 1369 (2018).","journal-title":"Front. Immunol."},{"key":"280_CR81","unstructured":"Buitinck, L. et al. API design for machine learning software: experiences from the scikit-learn project. Preprint at arXiv https:\/\/arxiv.org\/abs\/1309.0238 (2013)."},{"key":"280_CR82","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1109\/MCSE.2007.55","volume":"9","author":"JD Hunter","year":"2007","unstructured":"Hunter, J. D. Matplotlib: a 2D graphics environment. Comput. Sci. Eng. 9, 90\u201395 (2007).","journal-title":"Comput. Sci. Eng."},{"key":"280_CR83","doi-asserted-by":"publisher","first-page":"1389","DOI":"10.1109\/LSP.2014.2337313","volume":"21","author":"X Sun","year":"2014","unstructured":"Sun, X. & Xu, W. Fast implementation of DeLong\u2019s algorithm for comparing the areas under correlated receiver operating characteristic curves. IEEE Signal Process. Lett. 21, 1389\u20131393 (2014).","journal-title":"IEEE Signal Process. Lett."}],"container-title":["Nature Biotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41587-019-0280-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41587-019-0280-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41587-019-0280-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,11]],"date-time":"2024-12-11T17:28:53Z","timestamp":1733938133000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41587-019-0280-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10,14]]},"references-count":83,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2019,11]]}},"alternative-id":["280"],"URL":"https:\/\/doi.org\/10.1038\/s41587-019-0280-2","relation":{},"ISSN":["1087-0156","1546-1696"],"issn-type":[{"value":"1087-0156","type":"print"},{"value":"1546-1696","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,10,14]]},"assertion":[{"value":"22 February 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 September 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 October 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A.A.A. declares the following competing interests: stock or other ownership (CiberMed and Forty Seven); honoraria (Janssen Oncology); consulting or advisory roles (Celgene, Roche\/Genentech and Gilead Sciences); research funding (Celgene); patents, royalties or other intellectual property (patent filings on immune deconvolution and circulating tumor DNA detection assigned to Stanford University); and travel, accommodations or expenses (Roche and Gilead Sciences). R.B.A. declares the following competing interests: stock or other ownership (Personalis); consulting or advisory role (Pfizer, Youscript, 23andme and WithHealth); patents, royalties or other intellectual property (royalties for patents related to genome sequencing).","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}